This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Calprotectin Testing Market

Market Insights on Calprotectin Testing covering sales outlook, demand forecast & up-to-date key trends

Calprotectin Testing Market By Test Kits (Calprotectin ELISA Test Kits, Calprotectin Rapid Testing Kits), Sample (Stool, Blood Serum/Plasma), Indication (Irritable Bowel Syndrome (IBS), Ulcerative Colitis, Crohn's Disease, Colorectal Cancer) & Region - Forecast 2022 - 2032

Calprotectin Testing Market Outlook (2022-2032)

The global calprotectin testing market is set reach a valuation of US$ 190.6 Mn in 2022, exhibiting growth at a CAGR of 6.2%, surpassing US$ 348.2 by the end of 2032. According to the recent study, calprotectin ELISA test kits held a market share of 91.3% in 2021 in the global market.

Data Points

Market Insights

Calprotectin Testing Market Value 2021

US$ 180.8 Mn

Calprotectin Testing Market Value 2022

US$ 190.6 Mn

Calprotectin Testing Market Value 2032

US$ 348.2 Mn

Calprotectin Testing Market Growth Rate (2022-2032)

6.2% CAGR

Market Share of Top 5 Countries

57.5%

The market value for calprotectin testing holds approximately 0.2% of the overall US$ 98.2 Bn global In-vitro diagnostics market in 2021. Demand for calprotectin testing is expected to propel with rising prevalence of inflammatory bowel disease (IBD).

Inflammatory bowel disease is a chronic, relapsing, and inflammatory disease of the gastric system. Growing incidence of ulcerative colitis (UC) as well as crohn’s disease (CD) will boost the demand in the market.

For instance, a 2018 study conducted by the Crohn's and Colitis Foundation, Canada, reported that around 27,000 lived with IBD and this number is expected to reach 400,000 by 2030, which is around 50% rise in the prevalence of the disease.

Another study published in the Journal of Gastroenterology & Hepatology mentioned that around 6.8 million cases of IBD were recorded globally in the year 2017. The study also interpreted that there is going to be an upward trend in the future when it comes to IBD cases globally.

As per Future Market Insights, North America is expected to be the leading region in terms of the overall share of calprotectin testing market, accounting for around 31.4% of demand share. Growth is due to recent product launches after getting approvals from regulatory bodies such as FDA.

Customize this Report

Let us know your requirement to get
100% FREE customization

Sales Analysis of Calprotectin Testing from 2017 to 2021 Vs Market Outlook for 2022 to 2032

The overall sales of calprotectin testing increased at a CAGR of 4.2% from 2017 to 2021 owing to the adoption of advanced calprotectin testing kits. With the advantages of rapid test kits over other available tests found in the market i.e. ELISA test kits, adoption of rapid tests is expected to surge, aiding the growth in this segment.

Demand for calprotectin testing is rising with growing adoption of IBD distant monitoring. This is due to various advantages such as reducing the patient burden on the clinic and the healthcare practitioners (HCPS).

Sales are also expected to spur as these testing procedures reduces visits and admissions to the centres and has close monitoring over a longer period. Additionally, increase in quality of life for the patient can be achieved while at the convenience of the HCP.

Moreover, the cases of IBD and irritable bowel syndrome (IBS) are increasing, improving the need for active diagnostic testing for detecting the ailment early and proper treatment. Constant diet alterations in individuals raise the risk of IBS and IBD.

On the back of aforementioned factors, the calprotectin testing market is poised to expand at a CAGR of 6.2% from 2022 to 2032 globally.

What are the Key Opportunities for Calprotectin Testing Kits Manufacturers?

Faecal calprotectin (FC) has several applications such as a sensitive and non-invasive marker for gastrointestinal mucosal inflammation as well as a biomarker for cancer. Apart from regular ELISA kits, automated immunoassays, also have emerged as an alternative source of testing. This can potentially aid in the enhanced management of laboratory workload.

The rapid test kits have a huge potential to be used in primary care where the initial diagnosis can be done to rule out or determine the presence of IBD. This is improving the treatment rates globally.

In addition, the analytical capabilities are enhancing with increasing generation and availability of digital data due to big data methodologies. It will help in producing new insights to improve outcomes in many disciplines.

Such applications for the development of predictive models, precision medicine, epidemiological models, and drug discovery will improve the diagnosis and treatment of IBD. Further, the introduction of Big Data in calprotectin testing will create opportunities for growth in the market.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What are the Factors Restraining the Demand for Calprotectin testing?

Chances of results through calprotectin testing being less accurate are high; this can further lead to a false negative result and can hamper the treatment plan for the individual. This repetitive testing may cause discomfort for the patient and hamper the adoption of calprotectin testing in the market.

Furthermore, elevated calprotectin levels are suggestive of the possible presence of inflammation in the gastrointestinal system. However, high levels of calprotectin may not always suggest the presence of IBD. Therefore, it limits the growth of the market during the forecast period from 2022 to 2032.

Country-wise Insights

What Makes the U.S. the Largest Market for Calprotectin Testing?

“Rising Prevalence of Cancer to Increase the Adoption of Calprotectin Testing”

The U.S. is expected to dominate North America calprotectin testing market, with a total market share of about 82.0% in 2021. The trend is likely to continue throughout the forecast period.

As per FMI, the U.S. is the most lucrative market for calprotectin testing owing to the rise in prevalence of cancer in the region.

For instance, according to the Centre for Disease Control and Prevention, colorectal cancer ranks 4th among the top 10-cancer prevalence in the country. Investments and government support in conducting research in various sectors will attract more attention to the calprotectin testing market.

Why is the U.K. Considered a Lucrative Market for Calprotectin testing in Europe?

“Rising Incidence of IBS in the U.K. to Push the Demand for Calprotectin Testing”

The U.K. is set to exhibit a CAGR of nearly 6.4% in Europe calprotectin testing market during the forecast period.

According to the Journal of Clinical and Experimental Dermatology published article, skin lesions are a very common occurrence in irritable bowel syndrome (IBS). Hence, to cure skin issues, increasing focus on IBS will boost the market.

What Makes China an Emerging Market for Calprotectin testing?

“Increasing Adoption of Home Testing Kits to Fuel the Sales of Calprotectin Testing Kits”

China held 70.2% share in East Asia calprotectin testing market in 2021 and is projected to exhibit growth at a high CAGR rate of 7.9% during the forecast period. Growth is associated with an increasing focus on the home testing system.

In addition, rising healthcare costs and rapidly improving medical infrastructure are expected to drive the market during the forecast period.

What Makes India an Emerging Market for Calprotectin testing?

“Need for Early Disease Detection will Propel the Demand for Calprotectin Testing”

India held over 62.3% share in South Asia calprotectin testing market in 2021 and is projected to increase at a high CAGR rate of 8.8% during the forecast period. Growth is primarily due to advancements in the diagnostic system in India.

With the increasing prevalence of diseases, a dramatic scientific breakthrough resulted in increasing advancements in the disease diagnosis system. Hence, India market is considered to be an emerging market for calprotectin testing during the forecast period from 2022 to 2032.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Category-wise Insights

Which Calprotectin Testing Kit is Most Preferred?

“Calprotectin ELISA Test Kits to Remain Highly Sought-After”

Based on test kits, the calprotectin ELISA test kits segment will project a lucrative growth at a CAGR of 6.2% until 2032, as it provides more accurate results than other tests such as serological tests (ESR, CRP).

It helps in detecting inflammation in the intestines which is associated with some bacterial infections such as in people with inflammatory bowel disease (IBD).

Which Sample Type will Hold Significant Share in Calprotectin Testing Market?

“Preference for Non-Invasive Procedure to Increase the Demand for Calprotectin Stool Testing Demand”

Stool is expected to hold a similar share over the forecast period with the estimation being 88.7% in 2032. The stool is the most preferred sample because the stool test is non-invasive in nature.

It helps in distinguishing between IBD and IBS in an easy way. In addition, convenient sample collection is also contributing to the market share.

Which Indication will Hold Significant Share in the Global Calprotectin Testing Market?

“Surging Incidence of IBS to Improve the Demand for Calprotectin Testing”

Irritable Bowel Syndrome (IBS) held a revenue share of 78.0% in 2021. This is due to the highly accurate and cost-effective for determining the difference between IBS and IBD.

High prevalence of IBS in the world is also expected to contribute to enhancing the market growth from 2022 to 2032 to diagnose and prevent IBS.

Which is the Leading in the Calprotectin testing Market?

“More Than 2 Out of 5 Calprotectin Testing Sales to be Contributed by Hospitals”

Hospitals led the calprotectin testing market with more than 44.4% market share in 2021 as the patients prefer to be admitted to the hospital to seek treatment. Growth is also attributed to the presence of better medical diagnostic equipment and kits.

Furthermore, availability of highly skilled medical professionals that provide better treatment experience also contributed to the high market share during the coming years.

Competitive Landscape

Key players in the calprotectin testing market are focusing their efforts on expanding their geographical presence as well as product offerings as the key strategies. They are also enhancing their product portfolio together with market penetration.

For instance:

  • In August 2021, Boditech Med Inc. announced the extension of production capacity. The production capacity of instruments and cartridges was upgraded up to 30,000+ and 100,000,000+.
  • In August 2019, CerTest Biotec S.L. expanded its solutions for the diagnosis of infectious diseases in Japan and Germany.

Report Scope as per Calprotectin testing Industry Analysis

Attribute

Details

Forecast Period

2017-2021

Historical Data Available for

2022-2032

Market Analysis

US$ Mn for Value

Key Regions Covered

North America, Latin America, Europe, South Asia, East Asia, Oceania and Middle East & Africa

Key Countries Covered

US, China, Japan, Germany, Canada, UK, India, South Korea, Russia, Australia, BENELUX, Spain, Indonesia, France, Italy, Brazil, Thailand, Malaysia, Mexico, GCC, Argentina, South Africa, Turkey, and New Zealand

Key Market Segments Covered

Test Kits, Samples, Indication, End User and Region

Key Companies Profiled

  • Actim Oy
  • Calpro AS
  • BÜHLMANN Laboratories AG
  • EagleBio
  • CerTest Biotec S.L.
  • EUROIMMUN Medizinische Labordiagnostika AG
  • Boditech Med Inc.
  • Biohit Oyj
  • American Laboratory Products Company, Ltd.
  • DIAsource ImmunoAssays S.A
  • R-Biopharm AG.
  • Abbexa
  • AccuBio Tech Co., Ltd.
  • Screen Italia Srl.
  • Hangzhou Biotest Biotech Co., Ltd
  • Thermo Fisher Scientific
  • Epitope Diagnostics, Inc.
  • Elabscience Biotechnology Inc
  • Vitassay Healthcare, S.L.U.
  • Beckman Coulter Inc.
  • DiaSorin

Pricing

Available upon Request

Key Market Segments Covered in Calprotectin testing Industry Research

By Test Kits

  • Calprotectin ELISA Test Kits
  • Calprotectin Rapid Testing Kits

By Sample

  • Stool
  • Blood Serum/Plasma
  • Other Biological Samples

By Indication

  • Irritable Bowel Syndrome (IBS)
  • Ulcerative Colitis
  • Crohn's Disease
  • Colorectal Cancer

By End-User

  • Hospitals
  • Diagnostic Laboratories
  • Specialty Clinics

By Region

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East and Africa (MEA)

Frequently Asked Questions

The global calprotectin testing market is worth US$ 180.8 Mn in 2021 and is set to expand 1.8X over the next ten years.

The calprotectin testing market is expected to reach US$ 348.2 Mn by the end of 2032, with sales expected to increase at 6.2% CAGR.

Distant monitoring and E-health - the future of IBD patient care and novel developments in inflammatory bowel disease are some of the key trends being witnessed in this marketplace.

The U.S., China, India, Canada, and U.K. are expected to drive demand for the calprotectin testing industry.

North America is one of the key markets for calprotectin testing, with the U.S. expected to account for nearly 82.0% in 2021.

Demand for calprotectin testing in Europe is expected to register a growth of 5.2% over the next ten years.

The U.S., Germany and Spain are key producers of calprotectin testing products.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusion & Exclusion

3. Key Market Trends

    3.1. Key Trends Impacting The Market

    3.2. Innovation / Development Trends

4. Key Success Factors

    4.1. Patient Pathway for Faecal Calprotectin Testing

    4.2. Disease Epidemiology

    4.3. Adoption Analysis

    4.4. Promotional Strategies

    4.5. PESTLE 

    4.6. Porters Analysis

    4.7. Value Chain Analysis

    4.8. Product USP Analysis

    4.9. Regulatory Scenario 

    4.10. GAP Analysis

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global GDP Outlook 

        5.1.2. Increasing Spending on Healthcare Per Capita

        5.1.3. Global Life Expectancy outlook

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. Top Companies Historical Growth

        5.2.2. Increasing Adoption of Advance Calprotectin Testing Kits

        5.2.3. Increase Prevalence of Inflammatory Bowel Disease (IBD)

        5.2.4. Diagnosis rate (%)

        5.2.5. Average Number of Tests per Patients

        5.2.6. Cost Per Test (US$ Mn)

        5.2.7. Technological Advancements in Kits

        5.2.8. Regulatory Dynamics

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

6. COVID19 Crisis Analysis

    6.1. Current COVID-19 Statistics and Probable Future Impact

    6.2. Current GDP Projection and Probable Impact

    6.3. Current Economic Projection as Compared to 2008 Economic analysis

    6.4. COVID19 and Impact Analysis

        6.4.1.  By Test Kits

        6.4.2.  By Indication

        6.4.3.  By End User

        6.4.4. By Region

7. Europe Calprotectin Testing  Market - Pricing Analysis

    7.1. Regional Pricing Analysis By Test Kits

    7.2. Average Pricing Analysis Benchmark

    7.3. Pricing Assumptions

8. Global Calprotectin Testing Market Volume (Units) Analysis 2017-2021 and Forecast, 2022-2032

    8.1. Historical Market Volume (Units) Analysis, 2017-2021

    8.2. Current and Future Market Volume (Units) Projections, 2022-2032

        8.2.1. Y-o-Y Growth Trend Analysis

9. Global Calprotectin Testing Market Demand (in Value or Size in US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032

    9.1. Historical Market Value (US$ Mn) Analysis, 2017-2021

    9.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032

        9.2.1. Y-o-Y Growth Trend Analysis

        9.2.2. Absolute $ Opportunity Analysis

10. Global Calprotectin Testing Market Analysis 2017-2021 and Forecast 2022-2032, by Test Kits 

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis by Test Kits, 2017-2021

    10.3. Current and Future Market Size (US$ Mn) and Forecast by Test Kits, 2022-2032

            10.3.1.1. Calprotectin ELISA Kits

            10.3.1.2. Calprotectin Rapid Testing Kits

    10.4. Market Attractiveness Analysis by Test Kits 

11. Global Calprotectin Testing Market Analysis 2017-2021 and Forecast 2022-2032, by Indication

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Analysis by Indication, 2017-2021

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Indication, 2022-2032

        11.3.1. Irritable Bowel Syndrome (IBS)

        11.3.2. Ulcerative Colitis

        11.3.3. Crohn’s Disease

        11.3.4. Colorectal Cancer

    11.4. Market Attractiveness Analysis by Indication

12. Global Calprotectin Testing Market Analysis 2017-2021 and Forecast 2022-2032, by Sample 

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Mn) Analysis by Sample, 2017-2021

    12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Sample, 2022-2032

        12.3.1. Stool

        12.3.2. Blood Serum/Plasma

        12.3.3. Other Biological Samples

    12.4. Market Attractiveness Analysis by Sample

13. Global Calprotectin Testing Market Analysis 2017-2021 and Forecast 2022-2032, by End User 

    13.1. Introduction / Key Findings

    13.2. Historical Market Size (US$ Mn) Analysis by End User, 2017-2021

    13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by End User, 2022-2032

        13.3.1. Hospitals

        13.3.2. Diagnostic Laboratories

        13.3.3. Specialty Clinics

    13.4. Market Attractiveness Analysis by End User

14. Global Calprotectin Testing Market Analysis 2017-2021 and Forecast 2022-2032, by Region

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Analysis by Region, 2017-2021

    14.3. Current Market Size (US$ Mn) Analysis and Forecast by Region, 2022-2032

        14.3.1. North America

        14.3.2. Latin America

        14.3.3. Europe

        14.3.4. South Asia

        14.3.5. East Asia

        14.3.6. Oceania

        14.3.7. Middle East & Africa (MEA)

    14.4. Market Attractiveness Analysis by Region

15. North America Calprotectin Testing Market Analysis 2017-2021 and Forecast 2022-2032

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2017-2021

    15.3. Market Size (US$ Mn) Forecast by Market Taxonomy, 2022-2032

        15.3.1.  By Country

            15.3.1.1. U.S.

            15.3.1.2. Canada

        15.3.2. By Test Kits

        15.3.3. By Indication

        15.3.4. By Sample

        15.3.5. By End User

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Test Kits

        15.4.3. By Indication

        15.4.4. By Sample

        15.4.5. By End User

    15.5. Key Market Participants - Intensity Mapping

    15.6. Drivers and Restraints - Impact Analysis

16. Latin America Calprotectin Testing Market 2017-2021 and Forecast 2022-2032

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2017-2021

    16.3. Market Size (US$ Mn) Forecast by Market Taxonomy, 2022-2032

        16.3.1.  By Country

            16.3.1.1. Brazil

            16.3.1.2. Mexico

            16.3.1.3. Argentina

            16.3.1.4. Rest of Latin America

        16.3.2. By Test Kits

        16.3.3. By Indication

        16.3.4. By Sample

        16.3.5. By End User

    16.4. Market Attractiveness Analysis

        16.4.1. By Country

        16.4.2. By Test Kits

        16.4.3. By Indication

        16.4.4. By Sample 

        16.4.5. By End User

    16.5. Key Market Participants - Intensity Mapping

    16.6. Drivers and Restraints - Impact Analysis

17. Europe Calprotectin Testing Market 2017-2021 and Forecast 2022-2032

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2017-2021

    17.3. Market Size (US$ Mn) Forecast by Market Taxonomy, 2022-2032

        17.3.1.  By Country

            17.3.1.1. Germany

            17.3.1.2. Italy

            17.3.1.3. France

            17.3.1.4. U.K.

            17.3.1.5. Spain

            17.3.1.6. Finland

            17.3.1.7. Sweden

            17.3.1.8. Denmark

            17.3.1.9. Russia

            17.3.1.10. Rest of Europe

        17.3.2. By Test Kits

        17.3.3. By Indication

        17.3.4. By Sample

        17.3.5. By End User

    17.4. Market Attractiveness Analysis

        17.4.1. By Country

        17.4.2. By Test Kits

        17.4.3. By Indication

        17.4.4. By Sample

        17.4.5. By End User

    17.5. Key Market Participants - Intensity Mapping

    17.6. Drivers and Restraints - Impact Analysis

18. South Asia Calprotectin Testing Market 2017-2021 and Forecast 2022-2032

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2017-2021

    18.3. Market Size (US$ Mn) Forecast by Market Taxonomy, 2022-2032

        18.3.1.  By Country

            18.3.1.1. India

            18.3.1.2. Thailand

            18.3.1.3. Indonesia

            18.3.1.4. Malaysia

            18.3.1.5. Rest of South Asia

        18.3.2. By Test Kits

        18.3.3. By Indication

        18.3.4. By Sample

        18.3.5. By End User

    18.4. Market Attractiveness Analysis

        18.4.1. By Country

        18.4.2. By Test Kits

        18.4.3. By Indication

        18.4.4. By Sample 

        18.4.5. By End User

    18.5. Key Market Participants - Intensity Mapping

    18.6. Drivers and Restraints - Impact Analysis

19. East Asia Calprotectin Testing Market 2017-2021 and Forecast 2022-2032

    19.1. Introduction

    19.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2017-2021

    19.3. Market Size (US$ Mn) Forecast by Market Taxonomy, 2022-2032

        19.3.1.  By Country

            19.3.1.1. China

            19.3.1.2. Japan

            19.3.1.3. South Korea

        19.3.2. By Test Kits

        19.3.3. By Indication

        19.3.4. By Sample

        19.3.5. By End User

    19.4. Market Attractiveness Analysis

        19.4.1. By Country

        19.4.2. By Test Kits

        19.4.3. By Indication

        19.4.4. By Sample 

        19.4.5. By End User

    19.5. Key Market Participants - Intensity Mapping

    19.6. Drivers and Restraints - Impact Analysis

20. Oceania Calprotectin Testing Market 2017-2021 and Forecast 2022-2032

    20.1. Introduction

    20.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2017-2021

    20.3. Market Size (US$ Mn) Forecast by Market Taxonomy, 2022-2032

        20.3.1.  By Country

            20.3.1.1. Australia

            20.3.1.2. New Zealand

        20.3.2. By Test Kits

        20.3.3. By Indication

        20.3.4. By End User

        20.3.5. By Sample

        20.3.6. By End User

    20.4. Market Attractiveness Analysis

        20.4.1. By Country

        20.4.2. By Test Kits

        20.4.3. By Indication

        20.4.4. By Sample

        20.4.5. By End User

    20.5. Key Market Participants - Intensity Mapping

    20.6. Drivers and Restraints - Impact Analysis

21. Middle East and Africa Calprotectin Testing Market 2017-2021 and Forecast 2022-2032

    21.1. Introduction

    21.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2017-2021

    21.3. Market Size (US$ Mn) Forecast by Market Taxonomy, 2022-2032

        21.3.1.  By Country

            21.3.1.1. GCC Countries

            21.3.1.2. South Africa

            21.3.1.3. Turkey

            21.3.1.4. Rest of Middle East and Africa

        21.3.2. By Test Kits

        21.3.3. By Indication

        21.3.4. By Sample

        21.3.5. By End User

    21.4. Market Attractiveness Analysis

        21.4.1. By Country

        21.4.2. By Test Kits

        21.4.3. By Indication

        21.4.4. By Sample

        21.4.5. By End User

    21.5. Key Market Participants - Intensity Mapping

    21.6. Drivers and Restraints - Impact Analysis

22. Country Level Calprotectin Testing Market Analysis and Forecast 2022 & 2032

    22.1. Introduction

        22.1.1. Market Value Proportion Analysis

        22.1.2. Global VS. Country Growth Comparison

    22.2. U.S. Calprotectin Testing Market Analysis

        22.2.1. By Test Kits

        22.2.2. By Indication

        22.2.3. By Sample

        22.2.4. By End User

    22.3. Canada Calprotectin Testing Market Analysis

        22.3.1. By Test Kits

        22.3.2. By Indication

        22.3.3. By Sample

        22.3.4. By End User

    22.4. Brazil Calprotectin Testing Market Analysis

        22.4.1. By Test Kits

        22.4.2. By Indication

        22.4.3. By Sample

        22.4.4. By End User

    22.5. Mexico Calprotectin Testing Market Analysis

        22.5.1. By Test Kits

        22.5.2. By Indication

        22.5.3. By Sample

        22.5.4. By End User

    22.6. Argentina Calprotectin Testing Market Analysis

        22.6.1. By Test Kits

        22.6.2. By Indication

        22.6.3. By Sample

        22.6.4. By End User

    22.7. Germany Calprotectin Testing Market Analysis

        22.7.1. By Test Kits

        22.7.2. By Indication

        22.7.3. By Sample

        22.7.4. By End User

    22.8. Italy Calprotectin Testing Market Analysis

        22.8.1. By Test Kits

        22.8.2. By Indication

        22.8.3. By Sample

        22.8.4. By End User

    22.9. France Calprotectin Testing Market Analysis

        22.9.1. By Test Kits

        22.9.2. By Indication

        22.9.3. By Sample

        22.9.4. By End User

    22.10. U.K. Calprotectin Testing Market Analysis

        22.10.1. By Test Kits

        22.10.2. By Indication

        22.10.3. By Sample

        22.10.4. By End User

    22.11. Spain Calprotectin Testing Market Analysis

        22.11.1. By Test Kits

        22.11.2. By Indication

        22.11.3. By Sample

        22.11.4. By End User

    22.12. Finland Calprotectin Testing Market Analysis

        22.12.1. By Test Kits

        22.12.2. By Indication

        22.12.3. By Sample

        22.12.4. By End User

    22.13. Denmark Calprotectin Testing Market Analysis

        22.13.1. By Test Kits

        22.13.2. By Indication

        22.13.3. By Sample

        22.13.4. By End User

    22.14. Sweden Calprotectin Testing Market Analysis

        22.14.1. By Test Kits

        22.14.2. By Indication

        22.14.3. By Sample

        22.14.4. By End User

    22.15. Russia Calprotectin Testing Market Analysis

        22.15.1. By Test Kits

        22.15.2. By Indication

        22.15.3. By Sample

        22.15.4. By End User

    22.16. China Calprotectin Testing Market Analysis

        22.16.1. By Test Kits

        22.16.2. By Indication

        22.16.3. By Sample

        22.16.4. By End User

    22.17. Japan Calprotectin Testing Market Analysis

        22.17.1. By Test Kits

        22.17.2. By Indication

        22.17.3. By Sample

        22.17.4. By End User

    22.18. South Korea Calprotectin Testing Market Analysis

        22.18.1. By Test Kits

        22.18.2. By Indication

        22.18.3. By Sample

        22.18.4. By End User

    22.19. India Calprotectin Testing Market Analysis

        22.19.1. By Test Kits

        22.19.2. By Indication

        22.19.3. By Sample

        22.19.4. By End User

    22.20. ASEAN Calprotectin Testing Market Analysis

        22.20.1. By Test Kits

        22.20.2. By Indication

        22.20.3. By Sample

        22.20.4. By End User

    22.21. Australia Calprotectin Testing Market Analysis

        22.21.1. By Test Kits

        22.21.2. By Indication

        22.21.3. By Sample

        22.21.4. By End User

    22.22. New Zealand Calprotectin Testing Market Analysis

        22.22.1. By Test Kits

        22.22.2. By Indication

        22.22.3. By Sample

        22.22.4. By End User

    22.23. GCC Countries Calprotectin Testing Market Analysis

        22.23.1. By Test Kits

        22.23.2. By Indication

        22.23.3. By Sample

        22.23.4. By End User

    22.24. Turkey Calprotectin Testing Market Analysis

        22.24.1. By Test Kits

        22.24.2. By Indication

        22.24.3. By Sample

        22.24.4. By End User

    22.25. South Africa Calprotectin Testing Market Analysis

        22.25.1. By Test Kits

        22.25.2. By Indication

        22.25.3. By Sample

        22.25.4. By End User

23. Market Structure Analysis

    23.1. Market Analysis by Tier of Companies 

    23.2. Market Share Analysis of Top Players

    23.3. Market Presence Analysis

24. Competition Analysis

    24.1. Competition Dashboard

    24.2. Key Development Analysis

    24.3. Competition Deep Dive 

        24.3.1. Actim Oy

            24.3.1.1. Overview & Key Financials

            24.3.1.2. Product Portfolio

            24.3.1.3. Sales Footprint

            24.3.1.4. Analyst commentary

            24.3.1.5. Strategy

        24.3.2. Calpro AS

            24.3.2.1. Overview & Key Financials

            24.3.2.2. Product Portfolio

            24.3.2.3. Sales Footprint

            24.3.2.4. Analyst commentary

            24.3.2.5. Strategy

        24.3.3. BÜHLMANN Laboratories AG 

            24.3.3.1. Overview & Key Financials

            24.3.3.2. Product Portfolio

            24.3.3.3. Sales Footprint

            24.3.3.4. Analyst commentary

            24.3.3.5. Strategy

        24.3.4. EagleBio 

            24.3.4.1. Overview & Key Financials

            24.3.4.2. Product Portfolio

            24.3.4.3. Sales Footprint

            24.3.4.4. Analyst commentary

            24.3.4.5. Strategy

        24.3.5. CerTest Biotec S.L.

            24.3.5.1. Overview & Key Financials

            24.3.5.2. Product Portfolio

            24.3.5.3. Sales Footprint

            24.3.5.4. Analyst commentary

            24.3.5.5. Strategy

        24.3.6. EUROIMMUN Medizinische Labordiagnostika AG

            24.3.6.1. Overview & Key Financials

            24.3.6.2. Product Portfolio

            24.3.6.3. Sales Footprint

            24.3.6.4. Analyst commentary

            24.3.6.5. Strategy

        24.3.7. Boditech Med Inc.

            24.3.7.1. Overview & Key Financials

            24.3.7.2. Product Portfolio

            24.3.7.3. Sales Footprint

            24.3.7.4. Analyst commentary

            24.3.7.5. Strategy

        24.3.8. Biohit Oyj

            24.3.8.1. Overview & Key Financials

            24.3.8.2. Product Portfolio

            24.3.8.3. Sales Footprint

            24.3.8.4. Analyst commentary

            24.3.8.5. Strategy

        24.3.9. American Laboratory Products Company, Ltd.

            24.3.9.1. Overview & Key Financials

            24.3.9.2. Product Portfolio

            24.3.9.3. Sales Footprint

            24.3.9.4. Analyst commentary

            24.3.9.5. Strategy

        24.3.10. DIAsource ImmunoAssays S.A

            24.3.10.1. Overview & Key Financials

            24.3.10.2. Product Portfolio

            24.3.10.3. Sales Footprint

            24.3.10.4. Analyst commentary

            24.3.10.5. Strategy

        24.3.11. R-Biopharm AG.

            24.3.11.1. Overview & Key Financials

            24.3.11.2. Product Portfolio

            24.3.11.3. Sales Footprint

            24.3.11.4. Analyst commentary

            24.3.11.5. Strategy

        24.3.12. Abbexa

            24.3.12.1. Overview & Key Financials

            24.3.12.2. Product Portfolio

            24.3.12.3. Sales Footprint

            24.3.12.4. Analyst commentary

            24.3.12.5. Strategy

        24.3.13. AccuBio Tech Co., Ltd.

            24.3.13.1. Overview & Key Financials

            24.3.13.2. Product Portfolio

            24.3.13.3. Sales Footprint

            24.3.13.4. Analyst commentary

            24.3.13.5. Strategy

        24.3.14. Screen Italia Srl.

            24.3.14.1. Overview & Key Financials

            24.3.14.2. Product Portfolio

            24.3.14.3. Sales Footprint

            24.3.14.4. Analyst commentary

            24.3.14.5. Strategy

        24.3.15. Hangzhou Biotest Biotech Co., Ltd

            24.3.15.1. Overview & Key Financials

            24.3.15.2. Product Portfolio

            24.3.15.3. Sales Footprint

            24.3.15.4. Analyst commentary

            24.3.15.5. Strategy

        24.3.16. Thermo Fisher Scientific

            24.3.16.1. Overview & Key Financials

            24.3.16.2. Product Portfolio

            24.3.16.3. Sales Footprint

            24.3.16.4. Analyst commentary

            24.3.16.5. Strategy

        24.3.17. Epitope Diagnostics, Inc.

            24.3.17.1. Overview & Key Financials

            24.3.17.2. Product Portfolio

            24.3.17.3. Sales Footprint

            24.3.17.4. Analyst commentary

            24.3.17.5. Strategy

        24.3.18. Elabscience Biotechnology Inc

            24.3.18.1. Overview & Key Financials

            24.3.18.2. Product Portfolio

            24.3.18.3. Sales Footprint

            24.3.18.4. Analyst commentary

            24.3.18.5. Strategy

        24.3.19. Vitassay Healthcare, S.L.U.

            24.3.19.1. Overview & Key Financials

            24.3.19.2. Product Portfolio

            24.3.19.3. Sales Footprint

            24.3.19.4. Analyst commentary

            24.3.19.5. Strategy

        24.3.20. Beckman Coulter Inc.

            24.3.20.1. Overview & Key Financials

            24.3.20.2. Product Portfolio

            24.3.20.3. Sales Footprint

            24.3.20.4. Analyst commentary

            24.3.20.5. Strategy

        24.3.21. DiaSorin

            24.3.21.1. Overview & Key Financials

            24.3.21.2. Product Portfolio

            24.3.21.3. Sales Footprint

            24.3.21.4. Analyst commentary

            24.3.21.5. Strategy

25. Assumptions and Acronyms Used

26. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Calprotectin Testing Market Volume (Units) Analysis 2017–2021 and Forecast, 2022–2032, By Test Kits

Table 02: Global Calprotectin Testing Market Size (US $ Th) Analysis 2017–2021 and Forecast, 2022–2032, By Test Kits

Table 03: Global Calprotectin Testing Market Size (US $ Th) Analysis 2017–2021 and Forecast, 2022–2032, By Indication

Table 04: Global Calprotectin Testing Market Size (US $ Th) Analysis 2017–2021 and Forecast, 2022–2032, By Sample type

Table 05: Global Calprotectin Testing Market Size (US $ Th) Analysis 2017–2021 and Forecast, 2022–2032, By End User

Table 06: Global Calprotectin Testing Market Size (US $ Th) Analysis 2017–2021 and Forecast, 2022–2032, By Region

Table 07: North America Calprotectin Testing Market Size (US $ Th) Analysis 2017–2021 and Forecast 2022–2032, by Country

Table 08: North America Calprotectin Testing Market Volume (in Units) Analysis 2017–2021 and Forecast, 2022–2032, By Test Kits

Table 09: North America Calprotectin Testing Market Size (US $ Th) Analysis 2017–2021 and Forecast, 2022–2032, By Test Kits

Table 10: North America Calprotectin Testing Market Value (US $ Th) Analysis 2017–2021 and Forecast, 2022–2032, By Sample

Table 11: North America Calprotectin Testing Market Value (US $ Th) Analysis 2017–2021 and Forecast, 2022–2032, By Indication

Table 12: North America Calprotectin Testing Market Value (US $ Th) Analysis 2017–2021 and Forecast, 2022–2032, By End User

Table 13: Latin America Calprotectin Testing Market Size (US $ Th) Analysis 2017–2021 and Forecast 2022–2032, by Country

Table 14: Latin America Calprotectin Testing Market Volume (in Units) Analysis 2017–2021 and Forecast, 2022–2032, By Test Kits

Table 15: Latin America Calprotectin Testing Market Size (US $ Th) Analysis 2017–2021 and Forecast, 2022–2032, By Test Kits

Table 16: Latin America Calprotectin Testing Market Value (US $ Th) Analysis 2017–2021 and Forecast, 2022–2032, By Sample type

Table 17: Latin America Calprotectin Testing Market Value (US $ Th) Analysis 2017–2021 and Forecast, 2022–2032, By Indication

Table 18: Latin America Calprotectin Testing Market Value (US $ Th) Analysis 2017–2021 and Forecast, 2022–2032, By End User

Table 19: Europe Calprotectin Testing Market Size (US $ Th) Analysis 2017–2021 and Forecast 2022–2032, by Country

Table 20: Europe Calprotectin Testing Market Volume (in Units) Analysis 2017–2021 and Forecast, 2022–2032, By Test Kits

Table 21: Europe Calprotectin Testing Market Size (US $ Th) Analysis 2017–2021 and Forecast, 2022–2032, By Test Kits

Table 22: Europe Calprotectin Testing Market Value (US $ Th) Analysis 2017–2021 and Forecast, 2022–2032, By Sample type

Table 23: Europe Calprotectin Testing Market Value (US $ Th) Analysis 2017–2021 and Forecast, 2022–2032, By Indication

Table 24: Europe Calprotectin Testing Market Value (US $ Th) Analysis 2017–2021 and Forecast, 2022–2032, By End User

Table 25: South Asia Calprotectin Testing Market Size (US $ Th) Analysis 2017–2021 and Forecast 2022–2032, by Country

Table 26: South Asia Calprotectin Testing Market Volume (in Units) Analysis 2017–2021 and Forecast, 2022–2032, By Test Kits

Table 27: South Asia Calprotectin Testing Market Size (US $ Th) Analysis 2017–2021 and Forecast, 2022–2032, By Test Kits

Table 28: South Asia Calprotectin Testing Market Value (US $ Th) Analysis 2017–2021 and Forecast, 2022–2032, By Sample type

Table 29: South Asia Calprotectin Testing Market Value (US $ Th) Analysis 2017–2021 and Forecast, 2022–2032, By Indication

Table 30: South Asia Calprotectin Testing Market Value (US $ Th) Analysis 2017–2021 and Forecast, 2022–2032, By End User

Table 31: East Asia Calprotectin Testing Market Size (US $ Th) Analysis 2017–2021 and Forecast 2022–2032, by Country

Table 32: East Asia Calprotectin Testing Market Volume (in Units) Analysis 2017–2021 and Forecast, 2022–2032, By Test Kits

Table 33: East Asia Calprotectin Testing Market Size (US $ Th) Analysis 2017–2021 and Forecast, 2022–2032, By Test Kits

Table 34: East Asia Calprotectin Testing Market Value (US $ Th) Analysis 2017–2021 and Forecast, 2022–2032, By Sample type

Table 35: East Asia Calprotectin Testing Market Value (US $ Th) Analysis 2017–2021 and Forecast, 2022–2032, By Indication

Table 36: East Asia Calprotectin Testing Market Value (US $ Th) Analysis 2017–2021 and Forecast, 2022–2032, By End User

Table 37: Oceania Calprotectin Testing Market Size (US $ Th) Analysis 2017–2021 and Forecast 2022–2032, by Country

Table 38: Oceania Calprotectin Testing Market Volume (in Units) Analysis 2017–2021 and Forecast, 2022–2032, By Test Kits

Table 39: Oceania Calprotectin Testing Market Size (US $ Th) Analysis 2017–2021 and Forecast, 2022–2032, By Test Kits

Table 40: Oceania Calprotectin Testing Market Value (US $ Th) Analysis 2017–2021 and Forecast, 2022–2032, By Sample type

Table 41: Oceania Calprotectin Testing Market Value (US $ Th) Analysis 2017–2021 and Forecast, 2022–2032, By Indication

Table 42: Oceania Calprotectin Testing Market Value (US $ Th) Analysis 2017–2021 and Forecast, 2022–2032, By End User

Table 43: Middle East & Africa Calprotectin Testing Market Size (US $ Th) Analysis 2017–2021 and Forecast 2022–2032, by Country

Table 44: Middle East & Africa Calprotectin Testing Market Volume (in Units) Analysis 2017–2021 and Forecast, 2022–2032, By Test Kits

Table 45: Middle East & Africa Calprotectin Testing Market Size (US $ Th) Analysis 2017–2021 and Forecast, 2022–2032, By Test Kits

Table 46: Middle East & Africa Calprotectin Testing Market Value (US $ Th) Analysis 2017–2021 and Forecast, 2022–2032, By Sample type

Table 47: Middle East & Africa Calprotectin Testing Market Value (US $ Th) Analysis 2017–2021 and Forecast, 2022–2032, By Indication

Table 48: Middle East & Africa Calprotectin Testing Market Value (US $ Th) Analysis 2017–2021 and Forecast, 2022–2032, By End User

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Average Pricing Analysis Benchmark US$ per unit (2021)

Figure 02: Calprotectin ELISA Kits Pricing Analysis (US$) for Per Unit, By Region, 2021

Figure 03: Calprotectin Rapid Testing Kits Pricing Analysis (US$) for Per Unit, By Region, 2021

Figure 04: Global Calprotectin Testing Market Volume (Units) Analysis, 2017–2021

Figure 05: Global Calprotectin Testing Market Volume (Units) & Y-o-Y Growth (%) Forecast, 2022–2032

Figure 06: Global Calprotectin Testing Market Size (‘US $ Th) Analysis, 2017–2021

Figure 07: Global Calprotectin Testing Market Size (US $ Th) & Y-o-Y Growth (%) Forecast, 2022–2032

Figure 08: Global Calprotectin Testing Market Absolute $ Opportunity Analysis, 2022–2032

Figure 09: Global Calprotectin Testing Market Analysis by Test Kits–2022 & 2032

Figure 10: Global Calprotectin Testing Market Y-o-Y Growth Projections by Test Kits, 2022 – 2032

Figure 11: Global Calprotectin Testing Market Attractiveness Analysis, By Test Kits, 2022-2032

Figure 12: Global Calprotectin Testing Market Analysis by Indication–2022 & 2032

Figure 13: Global Calprotectin Testing Market Y-o-Y Growth Projections by Indication, 2022 – 2032

Figure 14: Global Calprotectin Testing Market Attractiveness Analysis, By Test Kits, 2022-2032

Figure 15: Global Calprotectin Testing Market Analysis by Sample type–2022 & 2032

Figure 16: Global Calprotectin Testing Market Y-o-Y Growth Projections by Sample type, 2022 – 2032

Figure 17: Global Calprotectin Testing Market Attractiveness Analysis, By Sample type, 2022-2032

Figure 18: Global Calprotectin Testing Market Analysis by End User–2022 & 2032

Figure 19: Global Calprotectin Testing Market Y-o-Y Growth Projections by End User, 2022 – 2032

Figure 20: Global Calprotectin Testing Market Attractiveness Analysis, By Test Kits, 2022-2032

Figure 21: Global Calprotectin Testing Market Analysis by Region–2022 & 2032

Figure 22: Global Calprotectin Testing Market Y-o-Y Growth Projections by Region, 2022 – 2032

Figure 23: Global Calprotectin Testing Market Attractiveness Analysis, By Region, 2022-2032

Figure 24: North America Calprotectin Testing Market Value Share, By Country (2022 E)

Figure 25: North America Calprotectin Testing Market Value Share, by Test Kits (2022 E)

Figure 26: North America Calprotectin Testing Market Value Share, By Indication (2022 E)

Figure 27: North America Calprotectin Testing Market Value Share, by Sample (2022 E)

Figure 28: North America Calprotectin Testing Market Value Share, by End User (2022 E)

Figure 29: North America Calprotectin Testing Market Size (‘US $ Th) Analysis, 2017–2021

Figure 30: North America Calprotectin Testing Market Size (US $ Th) & Y-o-Y Growth (%) Forecast, 2022–2032

Figure 31: North America Calprotectin Testing Market Attractiveness Analysis 2022-2032, By Country

Figure 32: North America Calprotectin Testing Market Attractiveness Analysis 2022-2032, By Test Kits

Figure 33: North America Calprotectin Testing Market Attractiveness Analysis 2022-2032, By Indication

Figure 34: North America Calprotectin Testing Market Attractiveness Analysis 2022-2032, By Sample

Figure 35: North America Calprotectin Testing Market Attractiveness Analysis 2022-2032, By End User

Figure 36: Latin America Calprotectin Testing Market Value Share, By Country (2022 E)

Figure 37: Latin America Calprotectin Testing Market Value Share, by Test Kits (2022 E)

Figure 38: Latin America Calprotectin Testing Market Value Share, By Indication (2022 E)

Figure 39: Latin America Calprotectin Testing Market Value Share, by Sample (2022 E)

Figure 40: Latin America Calprotectin Testing Market Value Share, by End User (2022 E)

Figure 41: Latin America Calprotectin Testing Market Size (‘US $ Th) Analysis, 2017–2021

Figure 42: Latin America Calprotectin Testing Market Size (US $ Th) & Y-o-Y Growth (%) Forecast, 2022–2032

Figure 43: Latin America Calprotectin Testing Market Attractiveness Analysis 2022-2032, By Country

Figure 44: Latin America Calprotectin Testing Market Attractiveness Analysis 2022-2032, By Test Kits

Figure 45: Latin America Calprotectin Testing Market Attractiveness Analysis 2022-2032, By Indication

Figure 46: Latin America Calprotectin Testing Market Attractiveness Analysis 2022-2032, By Sample

Figure 47: Latin America Calprotectin Testing Market Attractiveness Analysis 2022-2032, By End User

Figure 48: Europe Calprotectin Testing Market Value Share, By Country (2022 E)

Figure 49: Europe Calprotectin Testing Market Value Share, by Test Kits (2022 E)

Figure 50: Europe Calprotectin Testing Market Value Share, By Indication (2022 E)

Figure 51: Europe Calprotectin Testing Market Value Share, by Sample (2022 E)

Figure 52: Europe Calprotectin Testing Market Value Share, by End User (2022 E)

Figure 53: Europe Calprotectin Testing Market Size (‘US $ Th) Analysis, 2017–2021

Figure 54: Europe Calprotectin Testing Market Size (US $ Th) & Y-o-Y Growth (%) Forecast, 2022–2032

Figure 55: Europe Calprotectin Testing Market Attractiveness Analysis 2022-2032, By Country

Figure 56: Europe Calprotectin Testing Market Attractiveness Analysis 2022-2032, By Test Kits

Figure 57: Europe Calprotectin Testing Market Attractiveness Analysis 2022-2032, By Indication

Figure 58: Europe Calprotectin Testing Market Attractiveness Analysis 2022-2032, By Sample

Figure 59: Europe Calprotectin Testing Market Attractiveness Analysis 2022-2032, By End User

Figure 60: South Asia Calprotectin Testing Market Value Share, By Country (2022 E)

Figure 61: South Asia Calprotectin Testing Market Value Share, by Test Kits (2022 E)

Figure 62: South Asia Calprotectin Testing Market Value Share, By Indication (2022 E)

Figure 63: South Asia Calprotectin Testing Market Value Share, by Sample (2022 E)

Figure 64: South Asia Calprotectin Testing Market Value Share, by End User (2022 E)

Figure 65: South Asia Calprotectin Testing Market Size (‘US $ Th) Analysis, 2017–2021

Figure 66: South Asia Calprotectin Testing Market Size (US $ Th) & Y-o-Y Growth (%) Forecast, 2022–2032

Figure 67: South Asia Calprotectin Testing Market Attractiveness Analysis 2022-2032, By Country

Figure 68: South Asia Calprotectin Testing Market Attractiveness Analysis 2022-2032, By Test Kits

Figure 69: South Asia Calprotectin Testing Market Attractiveness Analysis 2022-2032, By Indication

Figure 70: South Asia Calprotectin Testing Market Attractiveness Analysis 2022-2032, By Sample

Figure 71: South Asia Calprotectin Testing Market Attractiveness Analysis 2022-2032, By End User

Figure 72: East Asia Calprotectin Testing Market Value Share, By Country (2022 E)

Figure 73: East Asia Calprotectin Testing Market Value Share, by Test Kits (2022 E)

Figure 74: East Asia Calprotectin Testing Market Value Share, By Indication (2022 E)

Figure 75: East Asia Calprotectin Testing Market Value Share, by Sample (2022 E)

Figure 76: East Asia Calprotectin Testing Market Value Share, by End User (2022 E)

Figure 77: East Asia Calprotectin Testing Market Size (‘US $ Th) Analysis, 2017–2021

Figure 78: East Asia Calprotectin Testing Market Size (US $ Th)) & Y-o-Y Growth (%) Forecast, 2022–2032

Figure 79: East Asia Calprotectin Testing Market Attractiveness Analysis 2022-2032, By Country

Figure 80: East Asia Calprotectin Testing Market Attractiveness Analysis 2022-2032, By Test Kits

Figure 81: East Asia Calprotectin Testing Market Attractiveness Analysis 2022-2032, By Indication

Figure 82: East Asia Calprotectin Testing Market Attractiveness Analysis 2022-2032, By Sample

Figure 83: East Asia Calprotectin Testing Market Attractiveness Analysis 2022-2032, By End User

Figure 84: Oceania Calprotectin Testing Market Value Share, By Country (2022 E)

Figure 85: Oceania Calprotectin Testing Market Value Share, by Test Kits (2022 E)

Figure 86: Oceania Calprotectin Testing Market Value Share, By Indication (2022 E)

Figure 87: Oceania Calprotectin Testing Market Value Share, by Sample (2022 E)

Figure 88: Oceania Calprotectin Testing Market Value Share, by End User (2022 E)

Figure 89: Oceania Calprotectin Testing Market Size (‘US $ Th) Analysis, 2017–2021

Figure 90: Oceania Calprotectin Testing Market Size (US $ Th)) & Y-o-Y Growth (%) Forecast, 2022–2032

Figure 91: Oceania Calprotectin Testing Market Attractiveness Analysis 2022-2032, By Country

Figure 92: Oceania Calprotectin Testing Market Attractiveness Analysis 2022-2032, By Test Kits

Figure 93: Oceania Calprotectin Testing Market Attractiveness Analysis 2022-2032, By Indication

Figure 94: Oceania Calprotectin Testing Market Attractiveness Analysis 2022-2032, By Sample

Figure 95: Oceania Calprotectin Testing Market Attractiveness Analysis 2022-2032, By End User

Figure 96: Middle East & Africa Calprotectin Testing Market Value Share, By Country (2022 E)

Figure 97: Middle East & Africa Calprotectin Testing Market Value Share, by Test Kits (2022 E)

Figure 98: Middle East & Africa Calprotectin Testing Market Value Share, By Indication (2022 E)

Figure 99: Middle East & Africa Calprotectin Testing Market Value Share, by Sample (2022 E)

Figure 100: Middle East & Africa Calprotectin Testing Market Value Share, by End User (2022 E)

Figure 101: Middle East & Africa Calprotectin Testing Market Size (‘US $ Th) Analysis, 2017–2021

Figure 102: Middle East & Africa Calprotectin Testing Market Size (US $ Th) & Y-o-Y Growth (%) Forecast, 2022–2032

Figure 103: Middle East & Africa Calprotectin Testing Market Attractiveness Analysis 2022-2032, By Country

Figure 104: Middle East & Africa Calprotectin Testing Market Attractiveness Analysis 2022-2032, By Test Kits

Figure 105: Middle East & Africa Calprotectin Testing Market Attractiveness Analysis 2022-2032, By Indication

Figure 106: Middle East & Africa Calprotectin Testing Market Attractiveness Analysis 2022-2032, By Sample

Figure 107: Middle East & Africa Calprotectin Testing Market Attractiveness Analysis 2022-2032, By End User

Figure 108: Global Calprotectin Testing Market Value Proportion Analysis, By Countries, 2022

Figure 109: Global Calprotectin Testing Market, Global Vs. Country Growth Y-o-Y (%) Comparison, 2022-2032

Figure 110: U.S. Calprotectin Testing Market Share Analysis (%) By Test Kits, 2022 & 2032

Figure 111: U.S. Calprotectin Testing Market Share Analysis (%) By Indication, 2022 & 2032

Figure 112: U.S. Calprotectin Testing Market Share Analysis (%) By Sample, 2022 & 2032

Figure 113: U.S. Calprotectin Testing Market Share Analysis (%) By End User, 2022 & 2032

Figure 114: Canada Calprotectin Testing Market Share Analysis (%) By Test Kits, 2022 & 2032

Figure 115: Canada Calprotectin Testing Market Share Analysis (%) By Indication, 2022 & 2032

Figure 116: Canada Calprotectin Testing Market Share Analysis (%) By Sample, 2022 & 2032

Figure 117: Canada Calprotectin Testing Market Share Analysis (%) By End User, 2022 & 2032

Figure 118: Brazil Calprotectin Testing Market Share Analysis (%) By Test Kits, 2022 & 2032

Figure 119: Brazil Calprotectin Testing Market Share Analysis (%) By Indication, 2022 & 2032

Figure 120: Brazil Calprotectin Testing Market Share Analysis (%) By Sample, 2022 & 2032

Figure 121: Brazil Calprotectin Testing Market Share Analysis (%) By End User, 2022 & 2032

Figure 122: Mexico Calprotectin Testing Market Share Analysis (%) By Test Kits, 2022 & 2032

Figure 123: Mexico Calprotectin Testing Market Share Analysis (%) By Indication, 2022 & 2032

Figure 124: Mexico Calprotectin Testing Market Share Analysis (%) By Sample, 2022 & 2032

Figure 125: Mexico Calprotectin Testing Market Share Analysis (%) By End User, 2022 & 2032

Figure 126: Argentina Calprotectin Testing Market Share Analysis (%) By Test Kits, 2022 & 2032

Figure 127: Argentina Calprotectin Testing Market Share Analysis (%) By Indication, 2022 & 2032

Figure 128: Argentina Calprotectin Testing Market Share Analysis (%) By Sample, 2022 & 2032

Figure 129: Argentina Calprotectin Testing Market Share Analysis (%) By End User, 2022 & 2032

Figure 130: UK Calprotectin Testing Market Share Analysis (%) By Test Kits, 2022 & 2032

Figure 131: UK Calprotectin Testing Market Share Analysis (%) By Indication, 2022 & 2032

Figure 132: UK Calprotectin Testing Market Share Analysis (%) By Sample, 2022 & 2032

Figure 133: UK Calprotectin Testing Market Share Analysis (%) By End User, 2022 & 2032

Figure 134: Germany Calprotectin Testing Market Share Analysis (%) By Test Kits, 2022 & 2032

Figure 135: Germany Calprotectin Testing Market Share Analysis (%) By Indication, 2022 & 2032

Figure 136: Germany Calprotectin Testing Market Share Analysis (%) By Sample, 2022 & 2032

Figure 137: Germany Calprotectin Testing Market Share Analysis (%) By End User, 2022 & 2032

Figure 138: France Calprotectin Testing Market Share Analysis (%) By Test Kits, 2022 & 2032

Figure 139: France Calprotectin Testing Market Share Analysis (%) By Indication, 2022 & 2032

Figure 140: France Calprotectin Testing Market Share Analysis (%) By Sample, 2022 & 2032

Figure 141: France Calprotectin Testing Market Share Analysis (%) By End User, 2022 & 2032

Figure 142: Italy Calprotectin Testing Market Share Analysis (%) By Test Kits, 2022 & 2032

Figure 143: Italy Calprotectin Testing Market Share Analysis (%) By Indication, 2022 & 2032

Figure 144: Italy Calprotectin Testing Market Share Analysis (%) By Sample, 2022 & 2032

Figure 145: Italy Calprotectin Testing Market Share Analysis (%) By End User, 2022 & 2032

Figure 146: Spain Calprotectin Testing Market Share Analysis (%) By Test Kits, 2022 & 2032

Figure 147: Spain Calprotectin Testing Market Share Analysis (%) By Indication, 2022 & 2032

Figure 148: Spain Calprotectin Testing Market Share Analysis (%) By Sample, 2022 & 2032

Figure 149: Spain Calprotectin Testing Market Share Analysis (%) By End User, 2022 & 2032

Figure 150: Russia Calprotectin Testing Market Share Analysis (%) By Test Kits, 2022 & 2032

Figure 151: Russia Calprotectin Testing Market Share Analysis (%) By Indication, 2022 & 2032

Figure 152: Russia Calprotectin Testing Market Share Analysis (%) By Sample, 2022 & 2032

Figure 153: Russia Calprotectin Testing Market Share Analysis (%) By End User, 2022 & 2032

Figure 154: Finland Calprotectin Testing Market Share Analysis (%) By Test Kits, 2022 & 2032

Figure 155: Finland Calprotectin Testing Market Share Analysis (%) By Indication, 2022 & 2032

Figure 156: Finland Calprotectin Testing Market Share Analysis (%) By Sample, 2022 & 2032

Figure 157: Finland Calprotectin Testing Market Share Analysis (%) By End User, 2022 & 2032

Figure 158: Denmark Calprotectin Testing Market Share Analysis (%) By Test Kits, 2022 & 2032

Figure 159: Denmark Calprotectin Testing Market Share Analysis (%) By Indication, 2022 & 2032

Figure 160: Denmark Calprotectin Testing Market Share Analysis (%) By Sample, 2022 & 2032

Figure 161: Denmark Calprotectin Testing Market Share Analysis (%) By End User, 2022 & 2032

Figure 162: Sweden Calprotectin Testing Market Share Analysis (%) By Test Kits, 2022 & 2032

Figure 163: Sweden Calprotectin Testing Market Share Analysis (%) By Indication, 2022 & 2032

Figure 164: Sweden Calprotectin Testing Market Share Analysis (%) By Sample, 2022 & 2032

Figure 165: Sweden Calprotectin Testing Market Share Analysis (%) By End User, 2022 & 2032

Figure 166: India Calprotectin Testing Market Share Analysis (%) By Test Kits, 2022 & 2032

Figure 167: India Calprotectin Testing Market Share Analysis (%) By Indication, 2022 & 2032

Figure 168: India Calprotectin Testing Market Share Analysis (%) By Sample, 2022 & 2032

Figure 169: India Calprotectin Testing Market Share Analysis (%) By End User, 2022 & 2032

Figure 170: Thailand Calprotectin Testing Market Share Analysis (%) By Test Kits, 2022 & 2032

Figure 171: Thailand Calprotectin Testing Market Share Analysis (%) By Indication, 2022 & 2032

Figure 172: Thailand Calprotectin Testing Market Share Analysis (%) By Sample, 2022 & 2032

Figure 173: Thailand Calprotectin Testing Market Share Analysis (%) By End User, 2022 & 2032

Figure 174: Malaysia Calprotectin Testing Market Share Analysis (%) By Test Kits, 2022 & 2032

Figure 175: Malaysia Calprotectin Testing Market Share Analysis (%) By Indication, 2022 & 2032

Figure 176: Malaysia Calprotectin Testing Market Share Analysis (%) By Sample, 2022 & 2032

Figure 177: Malaysia Calprotectin Testing Market Share Analysis (%) By End User, 2022 & 2032

Figure 178: Indonesia Calprotectin Testing Market Share Analysis (%) By Test Kits, 2022 & 2032

Figure 179: Indonesia Calprotectin Testing Market Share Analysis (%) By Indication, 2022 & 2032

Figure 180: Indonesia Calprotectin Testing Market Share Analysis (%) By Sample, 2022 & 2032

Figure 181: Indonesia Calprotectin Testing Market Share Analysis (%) By End User, 2022 & 2032

Figure 182: China Calprotectin Testing Market Share Analysis (%) By Test Kits, 2022 & 2032

Figure 183: China Calprotectin Testing Market Share Analysis (%) By Indication, 2022 & 2032

Figure 184: China Calprotectin Testing Market Share Analysis (%) By Sample, 2022 & 2032

Figure 185: China Calprotectin Testing Market Share Analysis (%) By End User, 2022 & 2032

Figure 186: Japan Calprotectin Testing Market Share Analysis (%) By Test Kits, 2022 & 2032

Figure 187: Japan Calprotectin Testing Market Share Analysis (%) By Indication, 2022 & 2032

Figure 188: Japan Calprotectin Testing Market Share Analysis (%) By Sample, 2022 & 2032

Figure 189: Japan Calprotectin Testing Market Share Analysis (%) By End User, 2022 & 2032

Figure 190: South Korea Calprotectin Testing Market Share Analysis (%) By Test Kits, 2022 & 2032

Figure 191: South Korea Calprotectin Testing Market Share Analysis (%) By Indication, 2022 & 2032

Figure 192: South Korea Calprotectin Testing Market Share Analysis (%) By Sample, 2022 & 2032

Figure 193: South Korea Calprotectin Testing Market Share Analysis (%) By End User, 2022 & 2032

Figure 194: Australia Calprotectin Testing Market Share Analysis (%) By Test Kits, 2022 & 2032

Figure 195: Australia Calprotectin Testing Market Share Analysis (%) By Indication, 2022 & 2032

Figure 196: Australia Calprotectin Testing Market Share Analysis (%) By Sample, 2022 & 2032

Figure 197: Australia Calprotectin Testing Market Share Analysis (%) By End User, 2022 & 2032

Figure 198: New Zealand Calprotectin Testing Market Share Analysis (%) By Test Kits, 2022 & 2032

Figure 199: New Zealand Calprotectin Testing Market Share Analysis (%) By Indication, 2022 & 2032

Figure 200: New Zealand Calprotectin Testing Market Share Analysis (%) By Sample, 2022 & 2032

Figure 201: New Zealand Calprotectin Testing Market Share Analysis (%) By End User, 2022 & 2032

Figure 202: South Africa Calprotectin Testing Market Share Analysis (%) By Test Kits, 2022 & 2032

Figure 203: South Africa Calprotectin Testing Market Share Analysis (%) By Indication, 2022 & 2032

Figure 204: South Africa Calprotectin Testing Market Share Analysis (%) By Sample, 2022 & 2032

Figure 205: South Africa Calprotectin Testing Market Share Analysis (%) By End User, 2022 & 2032

Figure 206: Turkey Calprotectin Testing Market Share Analysis (%) By Test Kits, 2022 & 2032

Figure 207: Turkey Calprotectin Testing Market Share Analysis (%) By Indication, 2022 & 2032

Figure 208: Turkey Calprotectin Testing Market Share Analysis (%) By Sample, 2022 & 2032

Figure 209: Turkey Calprotectin Testing Market Share Analysis (%) By End User, 2022 & 2032

Figure 210: GCC Countries Calprotectin Testing Market Share Analysis (%) By Test Kits, 2022 & 2032

Figure 211: GCC Countries Calprotectin Testing Market Share Analysis (%) By Indication, 2022 & 2032

Figure 212: GCC Countries Calprotectin Testing Market Share Analysis (%) By Sample, 2022 & 2032

Figure 213: GCC Countries Calprotectin Testing Market Share Analysis (%) By End User, 2022 & 2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Respiratory Pathogen Testing Kits Market

Published : June 2020

Healthcare

Stool Management Systems Market

Published : July 2021

Healthcare

Hepatitis B Diagnostic Tests Market

Published : January 2022

Healthcare

Nucleic Acid Testing Market

Published : December 2021

Google translate

Calprotectin Testing Market